ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE000R9FA4A0
Stock Name / FundiShares S&P 500 ESG UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity Type
Entity LEI 549300PZLRJB7M8H1057
ETF TickerESPX(USD) AS
ETF TickerESPX(USD) Euronext Amsterdam

Holdings detail for MRK

Stock NameMarks Electrical Group PLC
TickerMRK(GBX) LSE
TYPECommon Stock
CountryUK
ISINGB00BM8Q5G47
LEI2138007KN8TKPIXIQE92
TickerMRK(EUR) F

Show aggregate MRK holdings

News associated with MRK

Surprising Analyst 12-Month Target For FDL
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-22 08:04:45
IWD, JNJ, MCD, MRK: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 Value ETF (Symbol: IWD) where we have detected an approximate $565.9 million dollar inflow -- that's a 0.9% increase week over w - 2025-09-18 13:26:06
Daiichi Sankyo, Merck Say Raludotatug Deruxtecan Granted Breakthrough Therapy Designation
(RTTNews) - Daiichi Sankyo Company Limited (DSKYF) and Merck & Co Inc. (MRK) said on Monday that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation for their raludotatug deruxtecan for the treatment of adults with platinum-resistant epithelia - 2025-09-15 08:43:59
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-12 10:32:51
Guru Fundamental Report for MRK - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-11 10:33:21
Notable ETF Inflow Detected - VYM, JNJ, MRK, CME
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard High Dividend Yield ETF (Symbol: VYM) where we have detected an approximate $440.7 million dollar inflow -- that's a 0.7% increase week over - 2025-09-10 11:50:46
MRK Factor-Based Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-10 10:34:14
Daiichi Sankyo And Merck : Ifinatamab Deruxtecan Shows Promising Results In Phase 2 ES-SCLC Trial
(RTTNews) - Daiichi Sankyo (DSKYF, 4568.T) and Merck & Co Inc. (MRK) announced that Results from the IDeate-Lung01 phase 2 trial showed that ifinatamab deruxtecan (I-DXd) demonstrated clinically meaningful response rates in patients with previously treated extensive-stage small c - 2025-09-08 02:18:22
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-05 10:33:56
Pre-Market Most Active for Sep 5, 2025 : OPEN, TSLL, SCAG, SQQQ, MRK, NVDA, KO, AVGO, SNAP, FIG, WMT, NIO
The NASDAQ 100 Pre-Market Indicator is up 147.96 to 23,780.97. The total Pre-Market volume is currently 100,628,631 shares traded.The following are the most active stocks for the pre-market session: Opendoor Technologies Inc (OPEN) is +0.27 at $6.23, with 12,819,663 shares trade - 2025-09-05 09:29:53
Guru Fundamental Report for MRK - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-04 10:32:25
MRK Factor-Based Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-03 10:34:47
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-29 10:33:23
MRK's Strong Dividend History Helps it Reach 'Top Dividend Stock of the Dow'
Merck & Co Inc (Symbol: MRK) has been named as the ''Top Dividend Stock of the Dow'', according to Dividend Channel, which published its most recent ''DividendRank'' report. The report noted that among the components of the Dow Jones Industrial Average, MRK shares displayed b - 2025-08-28 08:50:04
MRK Factor-Based Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-27 10:34:49
MRK Quantitative Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-26 10:34:02
iShares MSCI ACWI ETF Experiences Big Outflow
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI ACWI ETF (Symbol: ACWI) where we have detected an approximate $429.5 million dollar outflow -- that's a 1.9% decrease week over week (f - 2025-08-25 13:36:45
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-22 10:34:21
Dow Movers: WMT, MRK
In early trading on Thursday, shares of Merck topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.2%. Year to date, Merck has lost about 13.8% of its value. And the worst performing Dow component thus far on the day is Walmart, tr - 2025-08-21 11:27:42
MRK Factor-Based Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-20 10:34:00
After Hours Most Active for Aug 19, 2025 : CSX, INTC, MRK, NVDA, IBN, KO, FUN, PEP, CX, WMT, HTZ, QQQ
The NASDAQ 100 After Hours Indicator is down -1.71 to 23,383.06. The total After hours volume is currently 259,932,235 shares traded.The following are the most active stocks for the after hours session: CSX Corporation (CSX) is -0.04 at $36.48, with 11,794,785 shares traded. Ove - 2025-08-19 17:24:59
Daiichi Sankyo Announces Breakthrough Therapy Designation For Ifinatamab Deruxtecan
(RTTNews) - Daiichi Sankyo announced that Ifinatamab deruxtecan has been granted Breakthrough Therapy Designation by the FDA for the treatment of adult patients with extensive-stage small cell lung cancer with disease progression on or after platinum-based chemotherapy. The FDA g - 2025-08-18 08:36:51
The Zacks Analyst Blog Highlights Merck, Palo Alto Networks, Freeport-McMoRan and Espey
Analysts spotlight Merck, Palo Alto Networks, Freeport-McMoRan, and Espey as innovation, contract wins, and industry trends shape growth prospects. - 2025-08-15 12:44:00
Noteworthy ETF Outflows: SUSL, MCD, DIS, MRK
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares ESG MSCI USA Leaders ETF (Symbol: SUSL) where we have detected an approximate $84.6 million dollar outflow -- that's a 8.7% decrease week ov - 2025-08-15 11:49:25
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-15 10:31:59
Top Analyst Reports for Merck, Palo Alto & Freeport
Merck leans on Keytruda growth and pipeline expansion, Palo Alto rides subscription security demand, and Freeport benefits from electrification-driven copper demand. - 2025-08-14 17:46:00
Stocks See Support As Bessent Calls for a Big Rate Cut
The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 15:15:33
MRK April 2026 Options Begin Trading
Investors in Merck & Co Inc (Symbol: MRK) saw new options become available today, for the April 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 246 days until expiration the newly available contra - 2025-08-14 14:30:24
Stocks See Support As Bessent Calls for a Big Rate Cut
The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 14:05:26
Stocks See Support As Bessent Calls for a Big Rate Cut
The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 12:17:47

iShares S&P 500 ESG UCITS ETF USD (Acc) MRK holdings

DateNumber of MRK Shares HeldBase Market Value of MRK SharesLocal Market Value of MRK SharesChange in MRK Shares HeldChange in MRK Base ValueCurrent Price per MRK Share HeldPrevious Price per MRK Share Held
2025-12-11 (Thursday)51,217USD 5,070,995MRK holding increased by 71191USD 5,070,9950USD 71,191 USD 99.01 USD 97.62
2025-12-10 (Wednesday)51,217USD 4,999,804MRK holding increased by 37389USD 4,999,8040USD 37,389 USD 97.62 USD 96.89
2025-12-09 (Tuesday)51,217MRK holding increased by 666USD 4,962,415MRK holding decreased by -38595USD 4,962,415666USD -38,595 USD 96.89 USD 98.93
2025-12-08 (Monday)50,551MRK holding increased by 438USD 5,001,010MRK holding increased by 3742USD 5,001,010438USD 3,742 USD 98.93 USD 99.72
2025-12-05 (Friday)50,113USD 4,997,268MRK holding decreased by -58633USD 4,997,2680USD -58,633 USD 99.72 USD 100.89
2025-12-04 (Thursday)50,113MRK holding increased by 434USD 5,055,901MRK holding decreased by -24770USD 5,055,901434USD -24,770 USD 100.89 USD 102.27
2025-12-03 (Wednesday)49,679USD 5,080,671MRK holding increased by 61602USD 5,080,6710USD 61,602 USD 102.27 USD 101.03
2025-12-02 (Tuesday)49,679USD 5,019,069MRK holding decreased by -39744USD 5,019,0690USD -39,744 USD 101.03 USD 101.83
2025-12-01 (Monday)49,679USD 5,058,813MRK holding decreased by -149037USD 5,058,8130USD -149,037 USD 101.83 USD 104.83
2025-11-28 (Friday)49,679USD 5,207,850MRK holding increased by 9936USD 5,207,8500USD 9,936 USD 104.83 USD 104.63
2025-11-27 (Thursday)49,679USD 5,197,914USD 5,197,9140USD 0 USD 104.63 USD 104.63
2025-11-26 (Wednesday)49,679USD 5,197,914MRK holding decreased by -51169USD 5,197,9140USD -51,169 USD 104.63 USD 105.66
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MRK by Blackrock for IE000R9FA4A0

Show aggregate share trades of MRK

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-09BUY66699.85096.055 96.435GBX 64,225 88.08
2025-12-08BUY43899.66097.810 97.995GBX 42,922 88.03
2025-12-04BUY434102.600100.540 100.746GBX 43,724 87.92
2025-11-17BUY21994.74092.675 92.882GBX 20,341 87.21
2025-11-13SELL-43694.26090.900 91.236GBX -39,779 87.15 Loss of -1,781 on sale
2025-11-07BUY66086.57085.240 85.373GBX 56,346 87.12
2025-11-03BUY65486.10082.340 82.716GBX 54,096 87.18
2025-10-17SELL-44684.89083.200 83.369GBX -37,183 87.20 Profit of 1,709 on sale
2025-10-15BUY44284.69083.610 83.718GBX 37,003 87.23
2025-10-07BUY21888.94087.140 87.320GBX 19,036 87.24
2025-09-24BUY1,55980.11579.330 79.409GBX 123,798 87.43
2025-09-11SELL-672 85.150* 87.51 Profit of 58,808 on sale
2025-08-29BUY1,30684.24083.280 83.376GBX 108,889 87.56
2025-08-06BUY21781.32079.270 79.475GBX 17,246 87.68
2025-07-31BUY72481.49077.850 78.214GBX 56,627 87.83
2025-07-22BUY21881.77079.870 80.060GBX 17,453 88.03
2025-07-14SELL-21884.30083.110 83.229GBX -18,144 88.30 Profit of 1,105 on sale
2025-07-02BUY22682.79081.894 81.983GBX 18,528 88.63
2025-06-30BUY1,03979.39078.380 78.481GBX 81,542 88.70
2025-06-27BUY1,15579.54078.140 78.280GBX 90,413 88.77
2025-06-26BUY43680.25078.370 78.558GBX 34,251 88.84
2025-06-18SELL-21880.31077.100 77.421GBX -16,878 89.25 Profit of 2,578 on sale
2025-06-17SELL-1,09080.70078.190 78.441GBX -85,501 89.33 Profit of 11,869 on sale
2025-06-13BUY1,57582.44081.450 81.549GBX 128,440 89.45
2025-06-05BUY21878.55077.250 77.380GBX 16,869 89.91
2025-05-30BUY1,302 76.840* 90.32
2025-05-22SELL-43478.36076.680 76.848GBX -33,352 90.89 Profit of 6,094 on sale
2025-05-19BUY2,170 77.230* 91.24
2025-05-16BUY21476.16574.368 74.547GBX 15,953 91.38
2025-05-14BUY217 73.470* 91.69
2025-05-01SELL-21784.57583.170 83.310GBX -18,078 92.74 Profit of 2,046 on sale
2025-04-30BUY28885.83083.790 83.994GBX 24,190 92.81
2025-04-23BUY64880.20078.240 78.436GBX 50,827 93.39
2025-04-17BUY21678.74676.880 77.067GBX 16,646 94.05
2025-04-17BUY21678.74676.880 77.067GBX 16,646 94.05
2025-04-11BUY96379.44076.360 76.668GBX 73,831 94.76
2025-04-07SELL-1,50583.21079.300 79.691GBX -119,935 95.47 Profit of 23,746 on sale
2025-04-04SELL-1,93586.26081.090 81.607GBX -157,910 95.64 Profit of 27,149 on sale
2025-03-31SELL-296 89.760* 95.93 Profit of 28,395 on sale
2025-03-21BUY61 93.110* 96.44
2025-03-18SELL-856 94.720* 96.52 Profit of 82,619 on sale
2025-03-17SELL-2,122 94.790* 96.54 Profit of 204,862 on sale
2025-03-13SELL-428 94.710* 96.60 Profit of 41,344 on sale
2025-03-11BUY898 94.730* 96.68
2025-03-10SELL-214 95.230* 96.70 Profit of 20,693 on sale
2025-03-05SELL-642 93.190* 96.83 Profit of 62,165 on sale
2025-03-03SELL-21492.79091.810 91.908GBX -19,668 96.96 Profit of 1,082 on sale
2025-02-21SELL-79689.53087.010 87.262GBX -69,461 97.66 Profit of 8,273 on sale
2025-02-14SELL-85684.76082.094 82.361GBX -70,501 99.00 Profit of 14,240 on sale
2025-02-12SELL-1,07086.67085.610 85.716GBX -91,716 99.59 Profit of 14,845 on sale
2025-02-10BUY21487.98086.270 86.441GBX 18,498 100.17
2025-02-05BUY3,00690.74087.995 88.270GBX 265,338 101.02
2025-02-03BUY428100.14598.000 98.214GBX 42,036 101.31
2025-01-31BUY1,935100.06098.580 98.728GBX 191,039 101.37
2025-01-29BUY1,07099.15097.390 97.566GBX 104,396 101.52
2025-01-28BUY19998.88096.590 96.819GBX 19,267 101.63
2025-01-24BUY21497.10095.410 95.579GBX 20,454 101.92
2024-12-09BUY201105.070102.330 102.604GBX 20,623 102.06
2024-12-06BUY2,782103.950102.690 102.816GBX 286,034 102.03
2024-12-03BUY856102.450100.620 100.803GBX 86,287 102.00
2024-12-02BUY214101.850100.460 100.599GBX 21,528 102.05
2024-11-29SELL-252103.040101.530 101.681GBX -25,624 102.07 Profit of 98 on sale
2024-11-08BUY1,491103.230101.020 101.241GBX 150,950 103.69
2024-10-31SELL-20103.23098.600 99.063GBX -1,981 105.25 Profit of 124 on sale
2024-10-30BUY212105.000102.900 103.110GBX 21,859 105.31
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MRK

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-191,053,2942,0243,869,11627.2%
2025-09-181,184,9228,0053,015,34039.3%
2025-09-171,616,76818,7303,647,85344.3%
2025-09-161,223,7119603,598,70934.0%
2025-09-151,814,7678,4204,295,96242.2%
2025-09-122,018,4637,5573,506,69457.6%
2025-09-111,493,7285,3993,180,82847.0%
2025-09-102,013,1025,3353,313,84760.7%
2025-09-091,075,1375,5052,373,81745.3%
2025-09-082,147,2042,4483,731,34357.5%
2025-09-051,440,1149,9482,983,29648.3%
2025-09-041,439,7261,1215,661,88725.4%
2025-09-031,849,1033,5534,699,60739.3%
2025-09-022,193,136115,1354,314,82650.8%
2025-08-291,545,05711,4203,841,71540.2%
2025-08-281,559,7666,1695,284,88829.5%
2025-08-271,383,4767,8383,737,50637.0%
2025-08-261,328,2351,2292,869,94446.3%
2025-08-252,177,2005,5783,771,31357.7%
2025-08-221,523,3527,4973,248,57546.9%
2025-08-212,449,66018,5405,416,96945.2%
2025-08-201,189,29116,6923,133,34538.0%
2025-08-191,722,6512,3313,737,68946.1%
2025-08-181,150,9372,8222,604,34444.2%
2025-08-151,795,3941,6733,415,80852.6%
2025-08-142,198,5622,2724,496,39848.9%
2025-08-131,885,48019,5373,953,04547.7%
2025-08-121,593,84410,3603,185,66750.0%
2025-08-11990,4053,6052,886,69034.3%
2025-08-081,224,37811,1872,672,27945.8%
2025-08-071,718,6615,3564,504,85038.2%
2025-08-062,028,9271,8824,007,25250.6%
2025-08-051,573,6816,0493,579,53444.0%
2025-08-041,568,9759443,301,80147.5%
2025-08-011,718,70113,8534,079,64242.1%
2025-07-313,367,7552,6646,082,64455.4%
2025-07-302,253,4585,8784,162,63654.1%
2025-07-295,939,07236,24911,111,79553.4%
2025-07-282,243,2356,7394,563,91349.2%
2025-07-251,302,4376,9002,889,20745.1%
2025-07-241,156,3972,5702,732,35142.3%
2025-07-231,879,40020,2804,001,02547.0%
2025-07-221,628,7541,7733,592,84745.3%
2025-07-211,900,56312,5715,188,43236.6%
2025-07-181,536,7621,2463,463,05944.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy